Review

Published on 18 Mar 2024

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Salvatore Crisafulli
Francesco Ciccimarra
Chiara Bellitto
Massimo Carollo
Elena Carrara
Lisa Stagi
Roberto Triola
Annalisa Capuano
Cristiano Chiamulera
Ugo Moretti

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1356405

2,554 views
1 citation

Editorial

Published on 06 Feb 2024

Editorial: Traditional and innovative approaches for signal detection

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Marco Tuccori
Andrew Bate
Ugo Moretti
Gianluca Trifirò

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1373689

774 views

Editorial

Published on 05 Feb 2024

Editorial: Treatment of comorbidities of asthma and its safety

in Respiratory Drug Safety

Serghei Covantsev
Alexandru Corlateanu

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1366847

730 views

Perspective

Published on 02 Feb 2024

External comparators and estimands

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Gerd Rippin

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1332040

1,362 views
3 citations

Systematic Review

Published on 31 Jan 2024

Menstrual disorders following COVID-19 vaccination: a review using a systematic search

in Vaccine Safety and Regulation

Veerle R. Smaardijk
Rana Jajou
Agnes Kant
Florence P. A. M. van Hunsel

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1338466

8,438 views
3 citations

Review

Published on 26 Jan 2024

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Paola Maria Cutroneo
Daniele Sartori
Marco Tuccori
Salvatore Crisafulli
Vera Battini
Carla Carnovale
Concetta Rafaniello
Annalisa Capuano
Elisabetta Poluzzi
Ugo Moretti

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1323057

6,112 views
21 citations

Perspective

Published on 24 Jan 2024

External Comparator Cohort studies - clarification of terminology

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Gerd Rippin
Joan Largent
Wilhelmina Elisabeth Hoogendoorn
Héctor Sanz
Jaclyn Bosco
Christina Mack

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1321894

2,031 views
1 citation

Review

Published on 21 Dec 2023

A review of the prescribing culture of anti-depressants across government districts in Northern Ireland

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Mark W. Ruddock
Joanne Watt
Mary Jo Kurth
John V. Lamont
Laura Mooney
Peter Fitzgerald

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1303572

1,343 views
1 citation

Review

Published on 14 Dec 2023

Safety of corticosteroid therapy in sarcoidosis treatment

in Respiratory Drug Safety

Alessandro Di Marco Berardino
Federico Mei
Lina Zuccatosta

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1319931

902 views

Correction

Published on 04 Dec 2023

Corrigendum: An industry perspective on the use of machine learning in drug and vaccine safety

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Jeffery L. Painter
Raymond Kassekert
Andrew Bate

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1244115

492 views

Original Research

Published on 23 Nov 2023

Drug target, class level, and PathFX pathway information share utility for machine learning prediction of common drug-induced side effects

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Han Jie Liu
Jennifer L. Wilson

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1287535

1,052 views

Review

Published on 07 Nov 2023

Promising treatment biomarkers in asthma

in Respiratory Drug Safety

Barbara Bonnesen
Jens-Ulrik S. Jensen
Alexander G. Mathioudakis
Alexandru Corlateanu
Pradeesh Sivapalan

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1291471

1,474 views
1 citation

Original Research

Published on 15 Sep 2023

Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Linda Wanika
Neil D. Evans
Michael J. Chappell

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1267623

654 views

Methods

Published on 06 Sep 2023

Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training requirements

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Tarek A. Hammad
Salman Afsar
Herve Le-Louet
Veronique F. Kugener

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1257732

2,959 views
2 citations

Original Research

Published on 25 Aug 2023

The risk of preterm labor after COVID-19 vaccination before and during pregnancy

in Maternal-Fetal Medicine

M. de Feijter
L. C. M. Vissers
L. Davidson
A. C. Kant
P. J. Woestenberg

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1235051

1,839 views
2 citations

Review

Published on 04 Aug 2023

Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?

in Substance-Based Medical Devices

Barbara Vigani
Silvia Rossi
Giuseppina Sandri
Maria Cristina Bonferoni
Carla M. Caramella

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1227763

3,662 views
4 citations

Navigation group

Articles

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

Editorial: Traditional and innovative approaches for signal detection

Editorial: Treatment of comorbidities of asthma and its safety

External comparators and estimands

Menstrual disorders following COVID-19 vaccination: a review using a systematic search

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

External Comparator Cohort studies - clarification of terminology

A review of the prescribing culture of anti-depressants across government districts in Northern Ireland

Safety of corticosteroid therapy in sarcoidosis treatment

Corrigendum: An industry perspective on the use of machine learning in drug and vaccine safety

Drug target, class level, and PathFX pathway information share utility for machine learning prediction of common drug-induced side effects

Promising treatment biomarkers in asthma

Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning

Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training requirements

The risk of preterm labor after COVID-19 vaccination before and during pregnancy

Mucoadhesive polymers in substance-based medical devices: functional ingredients or what else?